Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation—a narrative review from EAU endourology - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Addressing Clinical Failure Following Minimally Invasive Surgical Interventions for BPH: A Comparison of Repeat MIST and Traditional Resection, Enucleation, or Ablation—A Narrative Overview from EAU Endourology

  • By

  • Bogatova, Svetlana

  • Morozov, Andrey

  • Gauhar, Vineet

  • Lifshitz, David

  • Sukhanov, Roman

  • Ehrlich, Yaron

  • Asali, Murad

  • Krupinov, German

  • Golan, Shay

  • Somani, Bhaskar K.

  • Herrmann, Thomas R. W.

  • Enikeev, Dmitry

  • February 27, 2026

Share

Original Source(s)

Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation—a narrative review from EAU endourology

  • by Bogatova, Svetlana, Morozov, Andrey, Gauhar, Vineet, Lifshitz, David, Sukhanov, Roman, Ehrlich, Yaron, Asali, Murad, Krupinov, German, Golan, Shay, Somani, Bhaskar K., Herrmann, Thomas R. W., Enikeev, Dmitry

  • February 27, 2026

Related Content

Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis

  • August 1, 2026

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn’s and Colitis (PREdiCCt) prospective cohort study